SecBot SecBot
Insider Cluster (7 insiders) ·Filed Mar 3, 2026

ALNY

ALNYLAM PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago
Insider cluster: 2 insiders, $204K total
Actionable Insight • Neutral

No meaningful signal from this cluster, the sales are minor and likely part of pre-arranged 10b5-1 plans; the rest are standard compensation events. Traders should focus on clinical or regulatory developments rather than this activity.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$318.65
T+0 close · Mar 2, 2026 · via day close
Latest settled
−7.22%
T+60 · $295.63
Vs SPY
−17.54%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 3 $318.65entry
  2. T+1 · 9mo ago +2.71%α +1.95% · $327.30
  3. T+5 · 8mo ago +1.17%α +1.65% · $322.38
  4. T+20 · 8mo ago +3.83%α +8.24% · $330.87
  5. T+60 · 6mo ago −7.22%α −17.54% · $295.63
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A cluster of insider transactions at Alnylam Pharmaceuticals over the past week includes open-market sales by the CSO and EVP of R&D totaling $204K, alongside non-cash grant and derivative exercise events involving top executives including the CEO and CFO. The sales are small in absolute value and represent a negligible fraction of the company's $43.4B market cap, while the other transactions are routine equity compensation activities.

Key Financial Metrics

Direction
selling
Total Value
$203.9K
Insiders
7

Key Facts

  • CSO Kevin Fitzgerald sold $91,483 in shares (289 shares at $316.55) on March 3, 2026
  • EVP of R&D Pushkal Garg sold $112,443 in shares (355 shares at $316.74) on March 3, 2026
  • CEO Yvonne Greenstreet received a non-cash award of 13,844 shares and exercised 5,921 shares via derivative on February 27 and March 2
  • CFO Jeffrey Poulton and other C-suite executives received non-cash awards and exercised derivatives with no open-market impact
  • Total open-market sales in cluster: $204K, representing just 0.0005% of Alnylam's $43.4B market cap

Financial Impact

$204K in open-market sales, 0.0005% of market cap, immaterial

insider ownershipshare count (dilution from grants)

Risk Factors

  • Perception of insider selling ahead of a potential downturn, though magnitude is too small to support concern
  • Future dilution from equity grants, though typical for biotech firms

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (10 trades, 7d window)cluster-ALNY-1772673102389

Track record

15 reports on ALNY

Performance horizon

1 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +26.35% at T+5 after the Oct 23, 2026 report. 1 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $160.53 Now $159.73 −0.50% settles Nov 23
  2. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $165.50 Now $159.73 −3.49% settles Nov 23
  3. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $165.04 Now $159.73 −3.22% settles Nov 20
  4. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $165.04 Now $159.73 −3.22% settles Nov 20
  5. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $156.66 to $156.65 Now $159.73 +1.96% ▼ −0.01% −3.30% vs SPY
  6. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $156.66 to $156.65 Now $159.73 +1.96% ▼ −0.01% −3.30% vs SPY
  7. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $165.00 to $155.94 Now $159.73 −3.19% ▼ −5.49% −2.79% vs SPY
  8. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $174.00 to $156.66 Now $159.73 −8.20% ▼ −9.97% −5.24% vs SPY
  9. Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $224.03 to $165.00 Now $159.73 +28.70% ▲ +26.35% +25.79% vs SPY
  10. Aug 17, 202613w ago Court Ruling Neutral 4/10 Entry $228.61 to $240.08 Now $159.73 −30.13% ▲ +5.02% +5.22% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (9h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 4, 2026